|
Getting your Trinity Audio player ready...
|
A special segment highlighting next-generation solutions shaping last-mile logistics, healthcare technology, and pharmaceutical breakthroughs.
Health In Tech (NASDAQ: HIT) Shines at NYSE
Health In Tech, a fast-rising Insurtech platform leveraging third-party AI, was showcased during the June 14 airing of “New to The Street” filmed at the New York Stock Exchange. Chief Growth Officer Dustin Plantholt took center stage to discuss the company’s digital underwriting innovations and its transformative quote-to-card technology, streamlining how health plans are built, priced, and delivered.
“Health In Tech is reimagining the health insurance landscape with automation and real-time delivery of coverage solutions,” said Plantholt during the interview. “Our technology eliminates weeks of delay and inefficiencies by digitizing the entire benefits issuance process.”
NRx Pharmaceuticals (NASDAQ: NRXP) Advances Late-Stage Drug Innovations
Also featured was NRx Pharmaceuticals, a late-stage clinical biopharma company focused on critical care and neuropsychiatric conditions. The company is actively commercializing ZYESAMI (Aviptadil) for COVID-related respiratory failure and advancing NRX-100/101, a groundbreaking sequential drug therapy for bipolar depression with acute suicidal ideation.
NRXP’s pipeline is tackling high-mortality conditions with no approved treatments, positioning the company as a potential game-changer in CNS and pulmonary care. The Bloomberg segment highlighted its commitment to meeting urgent unmet medical needs through science-driven development.
Arrive AI (NASDAQ: ARAI) Patents AI-Powered Delivery Platform
Arrive AI, a developmental stage technology company behind a patented smart mailbox platform, also gained attention for securing its eighth U.S. patent—this time for its Arrive Points™ system’s ability to heat and cool contents on demand. The autonomous solution is designed for seamless last-mile delivery of sensitive items, including medications, food, and even biological samples.
“This patent is critical for enabling temperature-controlled delivery in sectors like healthcare,” said a company spokesperson. “We’re building infrastructure that will transform how people exchange goods through robots and drones—safely and intelligently.”
Though not yet operational commercially, Arrive AI’s autonomous logistics ecosystem represents a visionary leap toward fully automated, AI-powered, and secure delivery networks.
As each company paves the way in its domain—from AI-driven logistics and real-time insurance solutions to life-saving drug development—their appearances on Bloomberg TV reinforce growing investor interest in mission-driven innovation. With expanding patent portfolios, clinical momentum, and cutting-edge platforms, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT) and NRx Pharmaceuticals (NASDAQ: NRXP) are making powerful strides into the future.